FDA Approved: * December 17, 2021
Pharm Company: * INVAGEN PHARMS
Category: Acromegaly

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lanreotide Overview

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2. Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for s...

Read more Lanreotide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Lanreotide Forums: RSS Feed

Missed injection

Hi I was a week late with my lanreotide injection last month do I take this months on the date I should normally take it or do I take it a week late to make it the 4 weeks cycle? Many thanks Barbara ## Hi Barbara, From what I could gather, Lanreotide is usually given every 4 weeks for 3 months at a time. However, the prescribing packet for this drug notes that you should "contact your doctor for instructions if you miss an appointment for your lanreotide injection." So at this point it is now in your doctor's power to decided whether or not he should alter your dose of Somatuline Depot or the length of time in-between injections, based on his judgement towards your response to therapy. Have you not already discussed this with your doctor?


Possible Dosages for this and Related Drugs:

  • Injection: 120mg, 120mg/0.5ml, 60mg, 60mg/0.2ml, 90mg, 90mg/0.3ml
  • Solution: 120mg/0.5ml (120mg/0.5ml), 60mg/0.2ml (60mg/0.2ml), 90mg/0.3ml (90mg/0.3ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lanreotide: (3 results)

Sorted by National Drug Code
  • 69097-870 Lanreotide Acetate 120 mg/.5ml Subcutaneous Injection by Cipla USA Inc.
  • 69097-880 Lanreotide Acetate 60 mg/.2ml Subcutaneous Injection by Cipla USA Inc.
  • 69097-890 Lanreotide Acetate 90 mg/.3ml Subcutaneous Injection by Cipla USA Inc.

Other drugs which contain Lanreotide or a similar ingredient: (1 result)